Health Care — Alle selskaper
Blackstone Minerals Ltd
Blackstone Minerals Ltd has a negative return on equity of -11.56% and a negative return on assets of -11.63%, indicating poor capital efficiency and asset utilization. The company's liquidity posi…
Cengild Medical Bhd
Cengild Medical Bhd maintains a strong liquidity position, with a current ratio of 8.08, indicating a substantial buffer of current assets over current liabilities. However, the company reported ne…
Chhb.Kl
CHHB.KL's capital structure is characterized by a low debt-to-equity ratio of 0.07, indicating a conservative approach to leverage. However, the company's liquidity is rated as medium, and its curr…
Ehsi.Pk
EHSI.PK exhibits a strong liquidity position, with a current ratio of 3.35, indicating that the company has more than three times the current assets to cover its current liabilities. The company ho…
Goldenwell Biotech Inc
Goldenwell Biotech Inc has a current liquidity position characterized by a current ratio of 119.42, indicating strong short-term liquidity. The company has no long-term debt, and its debt-to-equity…
Hlyk.Pk
HLYK.PK exhibits a highly leveraged capital structure, with total liabilities of $7.46 million and total equity of -$5.76 million, resulting in a negative debt-to-equity ratio of -0.15. The company…
Ihgp.Pk
IHGP.PK has a negative equity position of -$4.105 billion and a debt-to-equity ratio of -1.52, indicating a significant reliance on debt financing and a weak capital structure. The company's liquid…
Instituto de Diagnostico SA
Instituto de Diagnostico SA maintains a market price of 2700.0, with a market capitalization of 414,261,718,200.0. The company's price-to-earnings ratio is 26.45, and its price-to-book ratio is 2.0…
Inno.Cd
INNO.CD has a current liquidity position characterized by a current ratio of 7.7, indicating strong short-term liquidity. However, the company reported negative net cash after subtracting total deb…
Islb.Ns
ISLB.NS maintains a strong capital structure with a debt-to-equity ratio of 0.03, indicating minimal leverage and a conservative approach to financing. The company's liquidity position is character…
Jeev.Bo
JEEV.BO's capital structure is characterized by a debt-to-equity ratio of 0.41, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current…
Kprn.Ns
KPRN.NS maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.29, indicating a low reliance on debt financing. The company's liquidity position is assessed as medi…
Kreb.Ns
KREB.NS exhibits a highly leveraged capital structure, with total liabilities of INR 31.53 billion and total equity of INR -1.46 billion, resulting in a debt-to-equity ratio of -1.45. The company's…
KT Medical Service Co Ltd
KTMSM.BK maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating limited leverage and a strong equity base. The company's liquidity position is mixed: while it ho…
PT UBC Medical Indonesia Tbk
The company maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.31, indicating a conservative leverage position. However, its liquidity position is assessed as medium,…
Lddd.Pk
LDDD.PK maintains a strong liquidity position, with a current ratio of 2.18, indicating the company can easily cover its short-term liabilities with its current assets. The company has no long-term…
Noxopharm Ltd
Noxopharm Ltd has a basic and diluted share count of 307,237,950, indicating no immediate dilution pressure from share issuance. However, the company's liquidity position could not be assessed due…
Neuroscientific Biopharmaceuticals Ltd
NSB.AX maintains a strong liquidity position, with a current ratio of 49.56, indicating a significant excess of current assets over current liabilities. The company's price-to-book ratio of 1.98 su…
Pfsf.Pk
PFSF.PK exhibits a negative equity position of -$162.46 million and no long-term debt, indicating a capital structure that is entirely equity-funded and currently in deficit. The company's liquidit…
Philadelphia Pharmaceuticals Industry Company PSC
The company maintains a relatively strong liquidity position, with a current ratio of 2.57, indicating that it has more than twice as many current assets as current liabilities. However, its operat…
Pyridam Farma Tbk PT
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 6.31, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a c…
Rht.Ax
ResMed operates with a debt-to-equity ratio of 0.4 and a current ratio of 1.28, indicating moderate liquidity and a balanced capital structure. However, the company has no cash and equivalents, and…
Salus Ljubljana dd
Salus Ljubljana dd maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.29, indicating a low reliance on debt financing. The company's liquidity position is chara…
Sdpc.Jk
The company's capital structure is characterized by a high debt-to-equity ratio of 2.57, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a cu…
Spea.Bo
SPEA.BO maintains a strong liquidity position, as evidenced by a current ratio of 5.5, indicating that the company has sufficient current assets to cover its current liabilities multiple times over…
Suda.Bo
SUDA.BO exhibits a debt-to-equity ratio of 1.3, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a current ratio of…
Syncom Formulations (India) Ltd
Syncom Formulations maintains a relatively strong liquidity position, with a current ratio of 2.59, indicating that it has more than twice the current assets to cover its current liabilities. Howev…
Tnph.Pk
TNPH.PK maintains a strong liquidity position, with a current ratio of 14.21, indicating a significant ability to cover short-term liabilities with its current assets. The company holds $8.226 mill…
Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS
The company maintains a strong capital structure with a debt-to-equity ratio of 0.05, indicating a low reliance on debt financing. However, its liquidity position is rated as medium, with negative…
Topicus.com Inc
Topicus.com Inc maintains a capital structure characterized by significant leverage, with a debt-to-equity ratio of 1.67 and total liabilities of €2.04 billion against total equity of €474 million.…
TherapeuticsMD Inc
TherapeuticsMD Inc has a market capitalization of $23.6 million and a price-to-book ratio of 0.88, indicating that the company is trading at a discount to its book value. The company has no long-te…
Vvtm.V
The company's capital structure is highly leveraged, with total liabilities of $794,158 million and total equity of -$775,382 million, resulting in a negative debt-to-equity ratio of -0.72. Liquidi…
Waterco Ltd
Waterco's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in source documents. The comp…
Jin Medical International Ltd
Jin Medical International Ltd maintains a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current rati…
Zhejiang Zhenyuan Share Co Ltd
Zhejiang Zhenyuan maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating a low reliance on debt financing. The company's liquidity position is characterized as m…
JPI Healthcare Co Ltd
JPI Healthcare Co Ltd has a market capitalization of KRW 4,977,765,000,000 and a price-to-earnings ratio of 36.12, indicating a relatively high valuation compared to its earnings. The company repor…
Jinhe Biotechnology Co Ltd
Jinhe Biotechnology maintains a debt-to-equity ratio of 1.15, indicating a moderate reliance on debt financing. The company's current ratio of 1.07 suggests it has just enough current assets to cov…
0455.Hk
The company's capital structure is characterized by a debt-to-equity ratio of 0.29, indicating a relatively conservative leverage position. However, the company is currently operating with a negati…
CKD Bio Corp
CKD Bio Corp has a market price of 17,930 KRW and a market capitalization of 98,363,244,870 KRW, with a price-to-earnings ratio of 34.74 and a price-to-book ratio of 0.78. The company's liquidity p…
Anterogen Co Ltd
Anterogen maintains a strong liquidity position with a current ratio of 78.12, indicating that its current assets significantly exceed its current liabilities. The company holds KRW 1.58 billion in…
1813.Two
The company's capital structure is characterized by a debt-to-equity ratio of 0.32, indicating a relatively conservative leverage position. Its liquidity position is marked by a current ratio of 1.…
188260.Kq
The company's capital structure is characterized by a debt-to-equity ratio of 1.05, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
194a.T
194A.T maintains a capital structure with a debt-to-equity ratio of 0.93, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a curre…
HLB Pep Co Ltd
HLB Pep Co Ltd exhibits a capital structure with a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a cur…
PCL Inc
PCL Inc's capital structure is characterized by a debt-to-equity ratio of 0.54, indicating a moderate reliance on debt financing. The company holds cash and equivalents of KRW 6,397.8 billion, but…
246720.Kq
The company's capital structure is characterized by a debt-to-equity ratio of 0.3, indicating a relatively conservative leverage position. Despite holding significant cash and equivalents of KRW 2,…
Guanhao Biotech Co Ltd
Guanhao Biotech maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.22, indicating a low reliance on debt financing. The company's liquidity position is characte…
Dirui Industrial Co Ltd
Dirui Industrial Co Ltd maintains a debt-to-equity ratio of 0.29, indicating a relatively conservative capital structure with equity financing playing a dominant role in its capital base. The compa…
Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co Ltd maintains a strong liquidity position, as evidenced by a current ratio of 11.02, indicating that the company has significantly more current assets than curre…
Hunan Jiudian Pharmaceutical Co Ltd
Hunan Jiudian Pharmaceutical Co Ltd maintains a relatively strong liquidity position, with a current ratio of 3.64, indicating that it has sufficient current assets to cover its current liabilities…
311a.T
311A.T has a strong liquidity position, as evidenced by a current ratio of 7.1, indicating that the company holds significantly more current assets than current liabilities. The company maintains a…
RP Bio lnc
RP Bio lnc's capital structure is characterized by a debt-to-equity ratio of 0.3, indicating a relatively conservative leverage position compared to the industry median of 0.8. The company maintain…
317690.Kq
The company's capital structure is characterized by a low debt-to-equity ratio of 0.24, indicating a conservative leverage profile. It holds a substantial amount of cash and equivalents, amounting…
TiumBio Co Ltd
TiumBio operates with a capital structure that shows a debt-to-equity ratio of 1.11, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current…
Y Biologics Inc
Y Biologics Inc maintains a strong liquidity position with cash and equivalents amounting to KRW 38,922,143,940, which significantly exceeds its total liabilities of KRW 29,200,450,880. The company…
Quratis Inc
Quratis Inc has a capital structure characterized by a debt-to-equity ratio of 0.56, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a…
354390.Kn
The company maintains a strong liquidity position, with a current ratio of 6.87, indicating a significant buffer of current assets over current liabilities. It also holds substantial cash and equiv…
359090.Kq
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 8,848,468,100, which represents 10.45% of total assets. The liquidity FPT (free cash flow to total liab…
Hancom Lifecare Inc
Hancom Lifecare Inc has a strong liquidity position, with cash and equivalents amounting to KRW 10,510,215,160, which is significantly higher than its short-term liabilities. The company's liquidit…
389030.Kq
The company has a high price-to-book ratio of 14.64, indicating that the market values the company significantly above its book value. The price-to-tangible-book ratio is also 14.64, suggesting tha…
StemCyte International Ltd
StemCyte's capital structure is characterized by a relatively low debt-to-equity ratio of 0.13, indicating a conservative leverage profile. The company holds TWD 98.4 million in cash and equivalent…
419540.Kq
The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage position. However, the company has negative operating and free cash flows,…
4556.T
The company maintains a strong liquidity position, with a current ratio of 4.0, indicating a robust ability to meet short-term obligations. Its cash and equivalents amount to ¥3,396,322,000, which…
456070.Kq
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 13,999,999,610, which is significantly higher than its total liabilities of KRW 24,309,226,940. The cur…
4575.T
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥2.83 billion, representing 92.7% of total assets. The liquidity FPT (free cash flow to total assets) is no…
461030.Kq
The company maintains a strong liquidity position, with a current ratio of 15.37, indicating a significant buffer of current assets over current liabilities. Its cash and equivalents amount to KRW…
464490.Kq
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 26.5 billion, representing a significant portion of its total assets of KRW 51.2 billion. The liquidity…
600807.Ss
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 13.62, indicating a significant reliance on debt financing. Despite a current ratio of 1.36, suggesting moderate…
Medeon Biodesign Inc
Medeon Biodesign Inc has a market capitalization of approximately TWD 8.6 billion and a price-to-book ratio of 5.83, indicating a premium valuation relative to its book value. The company's liquidi…
6586.Two
The company exhibits a highly liquid capital structure, with a current ratio of 19.47, indicating a strong ability to meet short-term obligations. Despite this, the company reported negative operat…
6659.Two
6659.TWO has a debt-to-equity ratio of 0.79, indicating a moderate level of leverage, and a current ratio of 1.15, suggesting limited short-term liquidity cushion. The company reported negative net…
Unicocell Biomed Co Ltd
Unicocell Biomed Co Ltd maintains a strong liquidity position with a current ratio of 37.98, indicating that its current assets significantly exceed its current liabilities. However, the company ha…
6827.Two
6827.TWO maintains a strong liquidity position, with a current ratio of 16.17, indicating a high ability to meet short-term obligations. The company holds cash and equivalents of TWD 112.28 million…
7881.Two
The company's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Acu.Ax
ACU.AX maintains a conservative capital structure with a low debt-to-equity ratio of 0.08, indicating minimal reliance on debt financing. The company's liquidity position is characterized as medium…
Arab Drug Company for Pharmaceuticals and Chemical Industries SAE
Arab Drug Company for Pharmaceuticals and Chemical Industries SAE maintains a debt-to-equity ratio of 1.19, indicating a moderate level of leverage. The company's liquidity is assessed as medium, w…
Ado.Ax
The company's capital structure is characterized by a debt-to-equity ratio of 0.62, indicating a moderate reliance on debt financing. Liquidity is assessed as medium, with a current ratio of 2.08,…
Akebia Therapeutics Inc
Akebia Therapeutics Inc (AKBA.O) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the lat…
ADF Foods Ltd
ADF Foods Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating a strong equity position relative to liabilities. The company's liquidity is assessed as med…
Asiv.Si
ASIV.SI exhibits a strong liquidity position, with a current ratio of 13.32, indicating that the company holds significantly more current assets than current liabilities. The company's cash and equ…
At1.Ax
The company's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative approach to leverage. However, the company's liquidity position is assessed as medi…
BibbInstruments AB
BibbInstruments AB has a current liquidity position characterized by a current ratio of 2.03, indicating that the company holds twice as many current assets as current liabilities. However, the com…
GlaxoSmithKline SAE
The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.08, indicating a conservative leverage position. However, the negative operating cash flow of -187,089…
B.M.P. Pharma Trading AG
BMPG.SG exhibits a strong liquidity position, with a current ratio of 53.44, indicating that the company holds significantly more current assets than current liabilities. However, the company's net…
BioNxt Solutions Inc
BioNxt Solutions Inc exhibits a highly leveraged capital structure, with total liabilities of CAD 6.92 million and total equity of CAD -6.13 million, resulting in a negative debt-to-equity ratio of…
Chl.Cm
CHL.CM maintains a conservative capital structure with a debt-to-equity ratio of 0.22, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as m…
Coral Laboratories Ltd
Coral Laboratories Ltd maintains a strong liquidity position, as evidenced by a current ratio of 6.18, indicating that the company has significantly more current assets than current liabilities. Th…
Dshm.Ns
DSHM.NS has a debt-to-equity ratio of 0.41, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity position is assessed as medium…
Gway.Cd
GWAY.CD's capital structure is characterized by a debt-to-equity ratio of 1.57, indicating a relatively high level of leverage. The company's liquidity position is assessed as medium, with a curren…
Hemogenyx Pharmaceuticals PLC
HEMO.L's capital structure is characterized by a debt-to-equity ratio of 1.68, indicating a relatively high level of leverage. The company holds $1.59 billion in cash and equivalents, but this is o…
Hexr.Kl
HEXR.KL's capital structure is characterized by a very low debt-to-equity ratio of 0.01, indicating a conservative leverage profile. The company's liquidity position is moderate, with a current rat…
Isrg.Ta
ISRG.TA has a high price-to-book ratio of 353.36, indicating that the market values the company significantly above its book value. The company's liquidity position is weak, as evidenced by a curre…
Janel Group LLC
JANL.PK has a liquidity position that is below the industry median, with a current ratio of 0.74, indicating that the company's current assets are less than its current liabilities. The company's c…
Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Ltd operates with a capital structure that includes a basic and diluted share count of 67.14 million shares, with no dilution observed in the latest reporting period. The…
Jth0.Mu
JTH0.MU has a liquidity position that is moderate, with a current ratio of 2.81, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free…
Mdnc.Pk
MDNC.PK maintains a strong liquidity position with a current ratio of 4.27, indicating the company can cover its short-term liabilities more than four times over. The company's liquidity_fpt score…
Miph.Ca
MIPH.CA maintains a debt-to-equity ratio of 1.27, indicating a moderate reliance on debt financing, and a current ratio of 1.25, suggesting it has sufficient short-term assets to cover its short-te…
Nacp.Ns
NACP.NS exhibits a capital structure with a debt-to-equity ratio of 0.45, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio…
Ndc.Hno
NDC.HNO maintains a strong liquidity position, with a current ratio of 2.56, indicating that the company has more than double the current assets to cover its current liabilities. The company also h…
PetVivo Holdings Inc
PetVivo operates with a liquidity position that is below the industry median, as evidenced by a current ratio of 0.74, indicating that the company's current liabilities exceed its current assets. T…
Colombo City Holdings PLC
Colombo City Holdings PLC maintains a strong liquidity position, with a current ratio of 4.75, indicating the company can cover its short-term liabilities more than four times over. However, the co…
Phg.Bk
The company maintains a strong liquidity position, with a current ratio of 4.93, indicating a robust ability to meet short-term obligations. The liquidity_fpt metric further supports this, showing…
Polyrizon Ltd
Polyrizon maintains a strong liquidity position, with a current ratio of 29.03, indicating a significant buffer of current assets over current liabilities. The company's cash and equivalents amount…
QMS Medical Allied Services Ltd
QMS Medical Allied Services Ltd maintains a debt-to-equity ratio of 0.44, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity…
Quet.Ns
Quetell's capital structure is characterized by a debt-to-equity ratio of 0.37, indicating a relatively conservative leverage position compared to the industry median of 0.52. The company's liquidi…
Rvx.To
RVX.TO's capital structure is characterized by a significant debt burden, with total liabilities of $96.91 million and total equity of -$88.96 million, resulting in a debt-to-equity ratio of -0.69.…
Sanc.Kl
SANC.KL maintains a strong liquidity position with a current ratio of 10.18, indicating a high ability to meet short-term obligations. However, the company reported negative net cash of MYR -391,67…
Sirona Biochem Corp
Sirona Biochem Corp has a liquidity position that is currently medium, with a current ratio of 1.47, indicating that the company has sufficient short-term assets to cover its short-term liabilities…
Thai Optical Group PCL
Thai Optical Group PCL maintains a debt-to-equity ratio of 0.55, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is characterized by a current…
Tri.Ax
TRI.AX has a liquidity position that is characterized by a current ratio of 1.86, indicating that the company has sufficient current assets to cover its current liabilities. However, the company's…
Unichem Laboratories Ltd
Unichem Laboratories Ltd maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.19, indicating a low reliance on debt financing. The company's liquidity position is asses…
Srivichai vejvivat PCL
Srivichai Vejvivat PCL maintains a strong capital structure with a low debt-to-equity ratio of 0.02, indicating minimal reliance on debt financing. The company's liquidity position is characterized…
Ysps.Kl
YSPS.KL maintains a strong liquidity position, with a current ratio of 5.27, indicating the company can easily cover its short-term liabilities with its current assets. The company's cash and equiv…
Ildong Holdings Co Ltd
Ildong Holdings exhibits a highly leveraged capital structure, with total liabilities of KRW 823.97 billion and total equity of KRW 30.96 billion, resulting in a debt-to-equity ratio of 12.23. The…
Guhan Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co Ltd has a debt-to-equity ratio of 0.22, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is assessed as m…
Yungjin Pharm Co Ltd
Yungjin Pharm maintains a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a current r…
006140.Kq
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 24,000,425,590, which is 41.3% of total assets. The liquidity FPT (free cash flow to total liabilities)…
014570.Kq
The company maintains a strong liquidity position, with a current ratio of 8.33, indicating a high ability to meet short-term obligations. Its cash and equivalents amount to KRW 4,847,182,630, and…
018620.Kq
The company's capital structure is characterized by a debt-to-equity ratio of 1.02, indicating a relatively balanced mix of debt and equity financing. However, the company's liquidity position is a…
Seoulin Bioscience Co Ltd
Seoulin Bioscience maintains a strong liquidity position, with a current ratio of 3.56, indicating the company can easily cover its short-term liabilities with its current assets. The company's liq…
058110.Kq
The company's capital structure is characterized by a debt-to-equity ratio of 0.44, indicating a relatively conservative leverage position compared to the industry median of 0.65. However, the comp…
Medipost Co Ltd
The company's capital structure is characterized by a low debt-to-equity ratio of 0.19, indicating a conservative leverage profile. With a current ratio of 1.33, Medipost maintains sufficient short…
Huons Global Co Ltd
Huons Global maintains a strong liquidity position with KRW 193.2 billion in cash and equivalents, but its long-term debt of KRW 312.5 billion results in a net cash deficit. The company's liquidity…
Extrawell Pharmaceutical Holdings Ltd
0950.Hk
The company maintains a relatively strong liquidity position, with a current ratio of 1.03, indicating that it can cover its short-term liabilities with its short-term assets. However, the free cas…
1134.Hk
The company's capital structure is characterized by a low debt-to-equity ratio of 0.06, indicating a conservative leverage position. However, the current ratio of 1.91 suggests moderate liquidity,…
140610.Kn
The company's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. However, its liquidity position is constrained, with a current…
175250.Kq
The company's capital structure is characterized by a debt-to-equity ratio of 1.17, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
SYN-Tech Chem & Pharm Co Ltd
SYN-Tech Chem & Pharm Co Ltd maintains a strong liquidity position, with a current ratio of 2.69 and cash and equivalents amounting to TWD 403.07 million, which represents 14.2% of total assets. Th…
180400.Kq
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 103,434,353,530, significantly exceeding its total liabilities of KRW 60,928,994,740. The current ratio…
190a.T
190A.T maintains a strong liquidity position, with cash and equivalents amounting to ¥2.55 billion, significantly exceeding its total liabilities of ¥244.34 million, resulting in a current ratio of…
Abion Inc
Abion Inc maintains a strong liquidity position with KRW 34,369,645,560 in cash and equivalents, representing 42.6% of total assets. The company's debt-to-equity ratio of 0.13 indicates a conservat…
2135.Hk
The company maintains a debt-to-equity ratio of 0.55, indicating a moderate level of leverage, and a current ratio of 0.77, suggesting potential liquidity constraints. Free cash flow stands at 8.22…
2189.Hk
The company maintains a market capitalization of HKD 470 million and a price-to-earnings ratio of 21.48, indicating a moderate valuation relative to its earnings. Its price-to-book ratio of 1.08 su…
Medinet Co Ltd
Medinet Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to ¥4.9 billion, representing 80% of total assets. The company's liquidity FPT score indicates a low liquid…
Aligned Genetics Inc
Aligned Genetics Inc maintains a strong liquidity position, with a current ratio of 4.24, indicating the company can easily cover its short-term liabilities with its current assets. The company's c…
SCL Science Inc
SCL Science Inc has a liquidity position that is below the industry median, with a current ratio of 2.44 and a negative net cash position after subtracting total debt. The company's cash and equiva…
Fujian Cosunter Pharmaceutical Co Ltd
Fujian Cosunter Pharmaceutical Co Ltd exhibits a weak capital structure and liquidity position, with a debt-to-equity ratio of 1.64 and a current ratio of 1.08, indicating limited short-term liquid…
Contec Medical Systems Co Ltd
Contec Medical Systems Co Ltd has a market price of 11.79 CNY, with a market capitalization of 4.74 billion CNY. The company's price-to-book ratio is 2.73, and its price-to-tangible-book ratio is a…
3373.Two
3373.TWO has a strong liquidity position, with a current ratio of 9.69, indicating that the company holds significantly more current assets than current liabilities. The company maintains no long-t…
383930.Kq
The company's capital structure is characterized by a debt-to-equity ratio of 1.44, indicating a relatively high level of leverage. Its liquidity position is assessed as medium, with a current rati…
3869.Hk
The company maintains a liquidity position with a current ratio of 1.62, indicating a moderate ability to meet short-term obligations. However, the debt-to-equity ratio of 2.1 suggests a relatively…
Bioteque Corp
Bioteque Corp maintains a strong capital structure with a debt-to-equity ratio of 0.17, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as…
Rossmax International Ltd
Rossmax International Ltd maintains a relatively balanced capital structure, with total equity of TWD 15.54 billion and total liabilities of TWD 30.07 billion, resulting in a debt-to-equity ratio o…
Savior Lifetec Corp
Savior Lifetec Corp maintains a strong liquidity position, with a current ratio of 11.06, indicating a high ability to meet short-term obligations. The company holds TWD 588 million in cash and equ…
GeneReach Biotechnology Corp
GeneReach Biotechnology Corp has a debt-to-equity ratio of 0.35, indicating a relatively conservative capital structure. However, the company reported negative operating cash flow of -461,000 TWD a…
4186.Two
4186.TWO has a debt-to-equity ratio of 0.87, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company holds cash and equivalents of TWD 140.7 milli…
4192.Two
4192.TWO maintains a strong liquidity position, with a current ratio of 21.37, indicating a significant excess of current assets over current liabilities. The company holds TWD 157,334,000 in cash…
432980.Kq
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 2,911,710,830, which is sufficient to cover its long-term debt of KRW 3,024,339,060. The liquidity FPT…
4598.T
The company's capital structure is characterized by a strong liquidity position, with cash and equivalents amounting to ¥338.8 million, which significantly exceeds its total liabilities of ¥156.5 m…